| 1 | 1nkemia IUCT Group SA (Spain) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 2 | Ablynx NV (Belgium) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 3 | Acesis Holdings Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 4 | Alopexx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 5 | Alpine Immune Sciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 6 | Ambrx Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 7 | Amniotics AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 8 | Ampio Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 9 | Antibe Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 10 | Apexigen Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 11 | Aptinyx Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 12 | Aravive Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 13 | Aridis Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 14 | Asarina Pharma AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 15 | Aslan Pharmaceuticals Ltd (Singapore) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 16 | Baudax Bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 17 | Bellerophon Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 18 | Bellicum Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 19 | Better Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 20 | Bio Synectics, Inc. (South Korea) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 21 | biOasis Technologies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 11/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 22 | Biotech-IgG Equity AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 23 | Braster SA (Poland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 24 | C4X Discovery Holdings PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 1/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 25 | Cannabis Global, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 5/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 26 | Cannasouth Ltd (New Zealand) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 27 | Cardax Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 28 | Ceapro Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 29 | Cerevel Therapeutics Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 30 | Chinook Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 31 | Cognetivity Neurosciences Ltd (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 10/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 32 | CohBar Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 33 | Comera Life Sciences Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 34 | Crown LiquidationCo NV in liquidatie (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 35 | Curative Biotechnology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 36 | CymaBay Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 37 | Darwin AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 38 | Decibel Therapeutics, Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 39 | Destiny Pharma PLC (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 40 | Dice Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 41 | eFFECTOR Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 42 | Eiger Biopharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 43 | Eloxx Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 44 | Emplicure AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 45 | Endonovo Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 46 | Enlighta Inc (British Virgin Islands) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 47 | Ergomed Group Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 48 | Evelo Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 49 | Evolutionary Genomics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 50 | F3 Platform Biologics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 51 | Freeline Therapeutics Holdings PLC (ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 52 | Fusion Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 53 | GeNeuro SA (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 54 | Genomic Vision SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 55 | Gracell Biotechnologies Inc (ADR) (China) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 56 | Gyroscope Therapeutics Holdings Ltd(ADR) (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2020 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 57 | Harpoon Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 58 | HAVN Life Sciences Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 1/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 59 | IBEX Technologies Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 1/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 60 | Icosavax Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 61 | Idogen AB (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 62 | Innoveren Scientific Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 63 | ISR Immune System Regulation Holding AB (publ) (Sweden) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 64 | IVERIC bio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 65 | Karuna Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 66 | Kazia Therapeutics Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 67 | Kinnate Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 68 | Landos Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 69 | Lexagene Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 11/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 70 | LianBio - ADR (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 71 | Liminal BioSciences Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 72 | Lirum Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 73 | Lophos Holdings Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 74 | Luna Innovations Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 75 | MagForce AG (Germany) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 76 | Manuka Inc (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 77 | Mirati Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 78 | Miromatrix Medical Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 79 | Myovant Sciences Ltd (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 80 | Nabriva Therapeutics PLC - ADR (Ireland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 81 | Obseva SA (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 82 | Ocean Biomedical Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 83 | Old Ayala Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 84 | Pardes Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 85 | Phenomex Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 86 | Pherecydes Pharma SA (France) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 87 | POINT Biopharma Global Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 88 | Point of Care Nano-Technology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 4/30/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 89 | Predictive Technology Group Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2021 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 90 | Prometheus Biosciences Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 91 | Psybio Therapeutics Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 92 | R J Biotech Ltd (India) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 93 | Rayont Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 94 | RayzeBio Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 95 | Regenicin Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 96 | Regnum Corp (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 97 | ReNeuron Group Plc (United Kingdom) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 98 | Rubius Therapeutics Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 99 | Science 37 Holdings Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 100 | Scopus Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 101 | Somalogic Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 102 | Spexis AG (Switzerland) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 103 | SQZ Biotechnologies Co (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 104 | Statera Biopharma Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 105 | Surface Oncology Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 106 | TCR2 Therapeutics Inc. (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 107 | THC Farmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 108 | Theralink Technologies Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 109 | Theseus Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 110 | Todos Medical Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 9/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 111 | Trex Wind-Down Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 112 | Tryp Therapeutics Inc (Canada) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 2/29/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 113 | Univo Pharmaceuticals Ltd (Israel) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 114 | US Stem Cell Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 115 | Vaxxinity Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 116 | VBI Vaccines Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 3/31/2024 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 117 | Vitaspring Biomedical Co. Ltd (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 10/31/2022 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 118 | Wellfully Ltd (Australia) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 12/31/2023 | News | SEC | Bankruptcy | Suits | Liens | 
  
    | 119 | Zynerba Pharmaceuticals Inc (United States) | FRISK® | Z'' | PAYCE® | DBT | Moody's | Fitch | DBRS | 6/30/2023 | News | SEC | Bankruptcy | Suits | Liens |